Connecting impairment, disability, and handicap in immune mediated polyneuropathies
- PMID: 12486276
- PMCID: PMC1738172
- DOI: 10.1136/jnnp.74.1.99
Connecting impairment, disability, and handicap in immune mediated polyneuropathies
Abstract
Background: In the World Health Organisation (WHO) International Classification of Impairments, Disabilities, and Handicaps (ICIDH), it is suggested that various levels of outcome are associated with one another. However, the ICIDH has been criticised on the grounds that it only represents a general, non-specific relation between its entities.
Objective: To examine the significance of the ICIDH in immune mediated polyneuropathies.
Methods: Four impairment measures (fatigue severity scale, MRC sum score, "INCAT" sensory sum score, grip strength with the Vigorimeter), five disability scales (nine hole peg test, 10 metres walking test, an overall disability sum score (ODSS), Hughes functional grading scale, Rankin scale), and a handicap scale (Rotterdam nine items handicap scale (RIHS9)) were assessed in 113 clinically stable patients (83 with Guillain-Barré syndrome, 22 with chronic inflammatory demyelinating polyneuropathy, eight with a gammopathy related polyneuropathy). Regression analyses with backward and forward stepwise strategies were undertaken to determine the correlation between the various levels of outcome (impairment on disability, impairment on handicap, disability leading to handicap, and impairment plus disability on handicap).
Results: Impairment measures explained a substantial part of disability (R(2) = 0.64) and about half of the variance in handicap (R(2) = 0.52). Disability measures showed a stronger association with handicap (R(2) = 0.76). Combining impairment and disability scales accounted for 77% of the variance in handicap (RIHS9) scores.
Conclusions: In contrast to some suggestions, support for the ICIDH model is found in the current study because significant associations were shown between its various levels in patients with immune mediated polyneuropathies. Further studies are required to examine other possible contributors to deficits in daily life and social functioning in these conditions.
Similar articles
-
Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies.J Neurol Neurosurg Psychiatry. 2002 May;72(5):596-601. doi: 10.1136/jnnp.72.5.596. J Neurol Neurosurg Psychiatry. 2002. PMID: 11971045 Free PMC article.
-
Comparison between impairment and disability scales in immune-mediated polyneuropathies.Muscle Nerve. 2003 Jul;28(1):93-100. doi: 10.1002/mus.10410. Muscle Nerve. 2003. PMID: 12811779 Clinical Trial.
-
Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group.Neurology. 2000 Feb 22;54(4):943-9. doi: 10.1212/wnl.54.4.943. Neurology. 2000. PMID: 10690990
-
Impairment, disability, or handicap in peripheral neuropathy: analysis of the use of outcome measures in clinical trials in patients with peripheral neuropathies.J Neurol Neurosurg Psychiatry. 1995 Aug;59(2):165-9. doi: 10.1136/jnnp.59.2.165. J Neurol Neurosurg Psychiatry. 1995. PMID: 7629531 Free PMC article. Review.
-
The International Classification of Impairments, Disabilities and Handicaps (ICIDH)--results and problems.Int J Rehabil Res. 1996 Mar;19(1):1-11. doi: 10.1097/00004356-199603000-00001. Int J Rehabil Res. 1996. PMID: 8730539 Review.
Cited by
-
Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy.Eur J Neurol. 2021 Jan;28(1):286-296. doi: 10.1111/ene.14501. Epub 2020 Oct 1. Eur J Neurol. 2021. PMID: 32876962 Free PMC article. Clinical Trial.
-
Compartmentalized microfluidic culture platform to study mechanism of paclitaxel-induced axonal degeneration.Exp Neurol. 2009 Jul;218(1):124-8. doi: 10.1016/j.expneurol.2009.04.017. Epub 2009 May 3. Exp Neurol. 2009. PMID: 19409381 Free PMC article.
-
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.Trials. 2016 Jul 25;17(1):345. doi: 10.1186/s13063-016-1466-2. Trials. 2016. PMID: 27455854 Free PMC article. Clinical Trial.
-
Three-year follow-up outcomes of adult patients with Guillain-Barré Syndrome after rehabilitation.Malawi Med J. 2023 Sep;35(3):156-162. doi: 10.4314/mmj.v35i3.4. Malawi Med J. 2023. PMID: 38362288 Free PMC article.
-
A randomized trial of diagnostic ultrasound to improve outcomes in focal neuropathies.Muscle Nerve. 2015 Nov;52(5):746-53. doi: 10.1002/mus.24884. Epub 2015 Sep 10. Muscle Nerve. 2015. PMID: 26296394 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical